
January 11, 2023
HighTide-HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations
· Global biopharmaceutical company focusing on metabolic and digestive diseases · Proceeds to fund clinical and business development ROCKVILLE, MD and SHENZHEN,…